Allurion Technologies, Inc. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
Allurion Technologies, Inc. (ALUR) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of $990.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-05-15
- Allurion Technologies, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was $990.00K, a 77.70% decline year-over-year.
- Allurion Technologies, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was -$7.63M.
- Allurion Technologies, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-06-30 was -$10.20M, a 431.17% decline year-over-year.
- Allurion Technologies, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-03-31 was $4.44M, a 101.82% increase year-over-year.
- Allurion Technologies, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was $13.51M.
- Allurion Technologies, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was -$9.07M, a 1395.71% decline from fiscal 2023.
- Allurion Technologies, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was $700.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month as first filed | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-03-31 | $990.00K 10-Q · filed 2026-05-15 | |||||
| 2025-12-31 | $13.51M 10-K · filed 2026-03-30 | |||||
| 2025-09-30 | -$7.63M 10-Q · filed 2025-11-17 | -$17.83M derived: sum of 2 quarters · filed 2025-11-17 | -$13.39M derived: sum of 3 quarters · filed 2026-05-15 | |||
| 2025-06-30 | -$10.20M 10-Q · filed 2025-11-17 | $10.20M 10-Q · filed 2025-08-19 | -$5.76M derived: sum of 2 quarters · filed 2026-05-15 | |||
| 2025-03-31 | $4.44M 10-Q · filed 2026-05-15 | -$4.44M 10-Q · filed 2025-05-15 | ||||
| 2024-12-31 | -$9.07M 10-K · filed 2026-03-30 | $9.07M 10-K · filed 2025-03-27 | ||||
| 2024-09-30 | -$8.87M 10-Q · filed 2025-11-17 | $8.87M 10-Q · filed 2024-11-13 | -$5.79M derived: sum of 2 quarters · filed 2025-11-17 | -$3.59M derived: sum of 3 quarters · filed 2025-11-17 | ||
| 2024-06-30 | $3.08M 10-Q · filed 2025-11-17 | -$3.08M 10-Q · filed 2024-08-14 | $5.28M derived: sum of 2 quarters · filed 2025-11-17 | |||
| 2024-03-31 | $2.20M 10-Q · filed 2025-11-17 | -$2.20M 10-Q · filed 2024-05-14 | ||||
| 2023-12-31 | $700.00K 10-K/A · filed 2025-08-28 | -$700.00K 10-K · filed 2024-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B |